Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Ordinary Shares, nominal value Euro 0.04 per share
-
Shares outstanding
-
105,365,368
-
Number of holders
-
57
-
Total 13F shares, excl. options
-
23,104,591
-
Shares change
-
+3,587,384
-
Total reported value, excl. options
-
$364,447,000
-
Value change
-
+$50,602,846
-
Number of buys
-
38
-
Number of sells
-
-20
-
Price
-
$15.78
Significant Holders of ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) as of Q4 2018
64 filings reported holding PRQR - ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share as of Q4 2018.
ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) has 57 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23,104,591 shares
of 105,365,368 outstanding shares and own 22% of the company stock.
Largest 10 shareholders include ADAGE CAPITAL PARTNERS GP, L.L.C. (3,735,507 shares), GOLDMAN SACHS GROUP INC (3,406,102 shares), JENNISON ASSOCIATES LLC (2,995,305 shares), UBS Group AG (2,854,433 shares), ORBIMED ADVISORS LLC (1,437,731 shares), Artal Group S.A. (1,400,000 shares), FMR LLC (1,081,366 shares), PERCEPTIVE ADVISORS LLC (722,523 shares), BlackRock Inc. (701,095 shares), and HSBC HOLDINGS PLC (500,000 shares).
This table shows the top 57 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.